Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 241

1.

Substantia nigra echogenicity and imaging of striatal dopamine transporters in Parkinson's disease: a cross-sectional study.

Bor-Seng-Shu E, Pedroso JL, Felicio AC, de Andrade DC, Teixeira MJ, Braga-Neto P, Batista IR, Barsottini OG, Borges V, Ferraz HB, Shih MC, Bressan RA, de Andrade LA, Walter U.

Parkinsonism Relat Disord. 2014 May;20(5):477-81. doi: 10.1016/j.parkreldis.2014.01.015. Epub 2014 Feb 6.

PMID:
24629800
2.
3.

Transcranial sonography of the substantia nigra and its correlation with DAT-SPECT in the diagnosis of Parkinson's disease.

Li DH, Zhang LY, Hu YY, Jiang XF, Zhou HY, Yang Q, Kang WY, Liu J, Chen SD.

Parkinsonism Relat Disord. 2015 Aug;21(8):923-8. doi: 10.1016/j.parkreldis.2015.05.024. Epub 2015 Jun 3.

PMID:
26066091
4.

Sensitivity and specificity of 99mTc-TRODAT-1 SPECT imaging in differentiating patients with idiopathic Parkinson's disease from healthy subjects.

Weng YH, Yen TC, Chen MC, Kao PF, Tzen KY, Chen RS, Wey SP, Ting G, Lu CS.

J Nucl Med. 2004 Mar;45(3):393-401.

5.

Substantia nigra echogenicity is correlated with nigrostriatal impairment in Machado-Joseph disease.

Pedroso JL, Bor-Seng-Shu E, Felício AC, Braga-Neto P, Hoexter MQ, Teixeira MJ, Bressan RA, Barsottini OG.

Parkinsonism Relat Disord. 2013 Aug;19(8):742-5. doi: 10.1016/j.parkreldis.2013.04.019. Epub 2013 May 13.

PMID:
23680416
6.

99mTc-TRODAT-1 imaging of multiple system atrophy.

Lu CS, Weng YH, Chen MC, Chen RS, Tzen KY, Wey SP, Ting G, Chang HC, Yen TC.

J Nucl Med. 2004 Jan;45(1):49-55.

7.

Dopamine transporter imaging using 99mTc-TRODAT-1 SPECT in Parkinson's disease.

Bor-Seng-Shu E, Felicio AC, Braga-Neto P, Batista IR, Paiva WS, de Andrade DC, Teixeira MJ, de Andrade LA, Barsottini OG, Shih MC, Bressan RA, Ferraz HB.

Med Sci Monit. 2014 Aug 11;20:1413-8. doi: 10.12659/MSM.890522.

8.
9.

Differential diagnosis of Parkinson's disease and vascular parkinsonism by (99m)Tc-TRODAT-1.

Tzen KY, Lu CS, Yen TC, Wey SP, Ting G.

J Nucl Med. 2001 Mar;42(3):408-13.

10.

Comparison of 99mTc-TRODAT-1 SPECT and 18 F-AV-133 PET imaging in healthy controls and Parkinson's disease patients.

Hsiao IT, Weng YH, Lin WY, Hsieh CJ, Wey SP, Yen TC, Kung MP, Lu CS, Lin KJ.

Nucl Med Biol. 2014 Apr;41(4):322-9. doi: 10.1016/j.nucmedbio.2013.12.017. Epub 2014 Jan 10.

PMID:
24503330
11.

Substantia nigra echogenicity: A structural correlate of functional impairment of the dopaminergic striatal projection in Parkinson's disease.

Weise D, Lorenz R, Schliesser M, Schirbel A, Reiners K, Classen J.

Mov Disord. 2009 Aug 15;24(11):1669-75. doi: 10.1002/mds.22665.

PMID:
19514075
12.

Crossover study of (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in Parkinson's disease patients.

Huang WS, Chiang YH, Lin JC, Chou YH, Cheng CY, Liu RS.

J Nucl Med. 2003 Jul;44(7):999-1005.

13.

Higher nigrostriatal dopamine neuron loss in early than late onset Parkinson's disease?--a [99mTc]-TRODAT-1 SPECT study.

Shih MC, Franco de Andrade LA, Amaro E Jr, Felicio AC, Ferraz HB, Wagner J, Hoexter MQ, Lin LF, Fu YK, Mari JJ, Tufik S, Bressan RA.

Mov Disord. 2007 Apr 30;22(6):863-6.

PMID:
17290452
14.

Investigating the role of 99mTc-TRODAT-1 SPECT imaging in idiopathic Parkinson's disease.

Geng Y, Shi GH, Jiang Y, Xu LX, Hu XY, Shao YQ.

J Zhejiang Univ Sci B. 2005 Jan;6(1):22-7.

15.

Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].

Iranzo A, Lomeña F, Stockner H, Valldeoriola F, Vilaseca I, Salamero M, Molinuevo JL, Serradell M, Duch J, Pavía J, Gallego J, Seppi K, Högl B, Tolosa E, Poewe W, Santamaria J; Sleep Innsbruck Barcelona (SINBAR) group.

Lancet Neurol. 2010 Nov;9(11):1070-7. doi: 10.1016/S1474-4422(10)70216-7. Epub 2010 Sep 16. Erratum in: Lancet Neurol. 2010 Nov;9(11):1045.

PMID:
20846908
16.

Imaging of dopamine transporters with technetium-99m TRODAT-1 and single photon emission computed tomography.

Bao SY, Wu JC, Luo WF, Fang P, Liu ZL, Tang J.

J Neuroimaging. 2000 Oct;10(4):200-3.

PMID:
11147397
17.

99mTc-TRODAT-1 SPECT study in early Parkinson's disease and essential tremor.

Wang J, Jiang YP, Liu XD, Chen ZP, Yang LQ, Liu CJ, Xiang JD, Su HL.

Acta Neurol Scand. 2005 Dec;112(6):380-5.

PMID:
16281920
18.

Diagnostic accuracy of [99mTc]TRODAT-1 SPECT imaging in early Parkinson's disease.

Chou KL, Hurtig HI, Stern MB, Colcher A, Ravina B, Newberg A, Mozley PD, Siderowf A.

Parkinsonism Relat Disord. 2004 Aug;10(6):375-9.

PMID:
15261880
19.

No correlation of substantia nigra echogenicity and nigrostriatal degradation in Parkinson's disease.

Lobsien E, Schreiner S, Plotkin M, Kupsch A, Schreiber SJ, Doepp F.

Mov Disord. 2012 Mar;27(3):450-3. doi: 10.1002/mds.24070. Epub 2012 Jan 11.

PMID:
22237792
20.

Evaluation of early-stage Parkinson's disease with 99mTc-TRODAT-1 imaging.

Huang WS, Lin SZ, Lin JC, Wey SP, Ting G, Liu RS.

J Nucl Med. 2001 Sep;42(9):1303-8.

Items per page

Supplemental Content

Write to the Help Desk